Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CRHR1 antagonists(Corticotropin-releasing factor receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H32N2O4 |
InChIKeyGDEWNDAIPHGUIE-UHFFFAOYSA-N |
CAS Registry1415353-93-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Preclinical | US | 30 Jan 2022 | |
Anxiety Disorders | Preclinical | DE | - | |
Depressive Disorder, Major | Preclinical | DE | - |